InvestorsHub Logo
Followers 9
Posts 682
Boards Moderated 0
Alias Born 03/11/2013

Re: None

Thursday, 09/22/2016 5:31:23 AM

Thursday, September 22, 2016 5:31:23 AM

Post# of 428391
http://seekingalpha.com/article/1901351-amarin-todays-market-is-underestimating-the-probable-success-of-reduce-it

A very very good article written back in Dec 2013 that predicted a lot of things unfolding today. I am actually agreeing with the RRR predictions here. I believe that the reason for not stopping at 1st Interim are related to the 2ndry EPs and not the PE RRR. Another thing we keep forgetting is how controversial is EPA for CVD. This is a game changer trial and we need to be patient to reap the rewards with really robust data. Imagine how much cynical doctors are about fish oil. This trial has more significance than any of us really imagine. The whole O3 DS multibillion dollar industry will be affected with the outcome of this trial and the one answer from this trail: are fish oils, O3, etc. really good for your heart. I noticed another new industry that has recently popped up and that is the eggs. O3 enriched eggs are popping up everywhere in the mainstream.

This is not a trial to mess. Too many eyes are soon going to be on Reduce-It. This is much much bigger.

Th author's replies to some of the questions are also very enlightening.

Read the large comment by danburydude. Very interesting too.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News